Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Moore

Showing results (231-240 of 354) with videos related to

Pageof 36
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 18, 2008
Quantification methods of folpet degradation products in plasma with HPLC-UV/DAD: application to an in vivo toxicokinetic study in ratsMireille Canal-Raffin, Mathilde Receveur, Béatrice Martinez, et al.
Clinical Pharmacology and Therapeutics|December 1, 2018
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial FibrillationPatrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Fundamental & Clinical Pharmacology|August 25, 2015
Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization databaseJulien Bezin, Pierre-Olivier Girodet, Sahondra Rambelomanana, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 23, 2026
Dual Antiplatelet Therapy beyond 1 Year after a Myocardial Infarction Compared with Low-Dose Aspirin Alone: A 3-Year Follow-Up Cohort Study Within the French SNDS Nationwide Claims DatabasePatrick Blin, Nicolas Danchin, Jacques Benichou, et al.
Archives of Internal Medicine|March 28, 2012
Antipsychotic use and myocardial infarction in older patients with treated dementiaAntoine Pariente, Annie Fourrier-Réglat, Thierry Ducruet, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2003
Risk factors for adverse events in analgesic drug users: results from the PAIN studyNicholas Moore, Andrew Charlesworth, Eric Van Ganse, et al.
Epidemiology (Cambridge, Mass.)|October 1, 2013
Relative risks from case-population dataNicholas Moore, Sinem Ezgi Gulmez, Patrick Blin, et al.
Drug Safety|September 13, 2012
Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in FranceAntoine Pariente, Paul Avillach, Francesco Salvo, et al.
Pharmacoepidemiology and Drug Safety|February 17, 2012
Administrative complexities for a European observational study despite directives harmonising requirementsSinem Ezgi Gülmez, Séverine Lignot-Maleyran, Corinne S de Vries, et al.
Pharmacoepidemiology and Drug Safety|May 15, 2013
Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databasesPaul Avillach, Francesco Salvo, Frantz Thiessard, et al.
Pageof 36

Showing results (231-240 of 354) with videos related to

Sort By:
Pageof 36
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 18, 2008
Quantification methods of folpet degradation products in plasma with HPLC-UV/DAD: application to an in vivo toxicokinetic study in ratsMireille Canal-Raffin, Mathilde Receveur, Béatrice Martinez, et al.
Clinical Pharmacology and Therapeutics|December 1, 2018
Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial FibrillationPatrick Blin, Caroline Dureau-Pournin, Yves Cottin, et al.
Fundamental & Clinical Pharmacology|August 25, 2015
Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization databaseJulien Bezin, Pierre-Olivier Girodet, Sahondra Rambelomanana, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 23, 2026
Dual Antiplatelet Therapy beyond 1 Year after a Myocardial Infarction Compared with Low-Dose Aspirin Alone: A 3-Year Follow-Up Cohort Study Within the French SNDS Nationwide Claims DatabasePatrick Blin, Nicolas Danchin, Jacques Benichou, et al.
Archives of Internal Medicine|March 28, 2012
Antipsychotic use and myocardial infarction in older patients with treated dementiaAntoine Pariente, Annie Fourrier-Réglat, Thierry Ducruet, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2003
Risk factors for adverse events in analgesic drug users: results from the PAIN studyNicholas Moore, Andrew Charlesworth, Eric Van Ganse, et al.
Epidemiology (Cambridge, Mass.)|October 1, 2013
Relative risks from case-population dataNicholas Moore, Sinem Ezgi Gulmez, Patrick Blin, et al.
Drug Safety|September 13, 2012
Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in FranceAntoine Pariente, Paul Avillach, Francesco Salvo, et al.
Pharmacoepidemiology and Drug Safety|February 17, 2012
Administrative complexities for a European observational study despite directives harmonising requirementsSinem Ezgi Gülmez, Séverine Lignot-Maleyran, Corinne S de Vries, et al.
Pharmacoepidemiology and Drug Safety|May 15, 2013
Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databasesPaul Avillach, Francesco Salvo, Frantz Thiessard, et al.
Pageof 36